PH&T SpA
http://www.wisesgr.it/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From PH&T SpA
Finance Watch: Scion Life Sciences Launches With $310m Inaugural VC Fund
Private Company Edition: Scion’s first fund exceeded its initial $250m fundraising goal. Also, The Column Group’s incubator raised a $400m-plus fund and Seroba’s fourth fund reaches $134m, while Neurona raised a $120m financing and Cour closed a $105m series A round.
Deal Watch: AbbVie Leads J.P. Morgan Deal Rush, But BI, Genentech And Lilly Also Big Players
As the usual flurry of deals coincides with the J.P. Morgan Healthcare Conference, AbbVie signed an mRNA pact with Anima and a cancer research tie-up with Immunome.
Deal Watch: Iktos Doubles Its 2022 Alliance Tally In Agreements With Galapagos, Zealand
French AI-driven drug design firm will employ multiple technology platforms in latest tie-ups. Apellis looks to augment Empaveli-led portfolio in C3 complement R&D alliance with Affilogic.
Embolic Protection: Unmet Clinical Need or Unneeded Technology
While the debate continues about whether embolic protection devices are really necessary, the space continues to generate interest from investors, start-ups and large companies looking for new technologies. Despite the unfulfilled promise of the past decade, interest has spread to new interventional applications such as percutaneous heart valves, indicating that this area remains a viable opportunity for start-ups.
Company Information
- Industry
- Biotechnology
- Contract Research, Toxicology Testing-CRO
- Digital Health
- Distributors
- Diversified
- In Vitro Diagnostics
- Laboratory Testing Services
- Medical Devices
- Miscellaneous
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
- Services
- Academic and Research Institutions
- Contract Manufacturing Organization
-
Services
- Consulting Services
- Diagnostic Imaging Services
- Group Purchasing
- Home Infusion
- Hospitals, Nursing Homes, Institutions
- Managed Care, Insurance, Integrated Systems
- Outcomes Studies
- Pharmacy Services, PBMs
- Services sold to health care facilities
- Specialized outpatient services
- Utilization Review, Claims Processing, Cost Contai
-
Managed Care, Insurance, Integrated Systems
- Specialized Provider Networks
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
Pharmaceuticals
- Chiral Chemistry
- Drug Delivery
- Generic Drugs
- Nutraceuticals
- OTC, Consumer
- Radiopharmaceuticals, Contrast Agents
- Specialty Pharmaceuticals
- Vaccines
-
Drug Delivery
- Controlled Release
- Macromolecule
- Nasal
- Pulmonary
- Site Specific
- Topical Delivery
- Transdermal
-
Medical Devices
- Biomaterials
- Consumables, Central Supplies
- Diagnostic Equipment & Supplies
- Diagnostic Imaging Equipment & Supplies
- Implantable Devices
- Infection Control-Sterilization
- Infusion Therapy Equipment and Supplies
- Laser
- Monitoring Equipment & Devices
- Radiofrequency Devices
- Rehabilitation Equipment and Devices
- Surgical Equipment & Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Sealants
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Molecular Imaging
- MRI, NMR
- Pacs (Picture Archive & Communications Systems)
- Ultrasound
- X-ray
-
Laboratory Testing Services
- Anatomical Pathology
- Esoteric Laboratories
-
In Vitro Diagnostics
- Biosensors
- Chemistry, Immunoassay
- Cytology
- Glucose Testing
- Hematology, Coagulation
- Molecular Diagnostics & Genetic Testing
- Saliva-based Testing
- Therapeutic Drug Monitoring
- Urine-based Testing
-
Biotechnology
- Antisense, Oligonucleotides
- Drug Discovery Tools
- Gene Therapy, Cell Therapy
- Large Molecule
- Liposomes
- Nanotechnology, Chips, etc.
- Pharmacogenetics-Pharmacogenomics
- Synthesis Technologies, Production Processes
- Transgenics
-
Large Molecule
- Antibodies
-
Drug Discovery Tools
- ADMET
- Bioinformatics
- Genomics-Proteomics
- Molecular Diversity
-
Molecular Diversity
- Natural Products
- Other Names / Subsidiaries
-
- Wise
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice